Galveston, TXNCT05672927Now EnrollingIRB Ready

Immunization Clinical Trial in Galveston, TX

Access cutting-edge immunization treatment through this clinical trial at a research site in Galveston. Study-provided care at no cost to qualified participants.

Sponsored by The University of Texas Medical Branch, Galveston

Quick Self-Assessment

See if you qualify for this Galveston location

Preparing your pre-screening questions…

Expert Care in Galveston

Access immunization specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related immunization treatment provided free

Apply for This Galveston Location

Check if you qualify for this immunization clinical trial in Galveston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Galveston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Galveston site if eligible
  4. 4Begin participation

About This Immunization Study in Galveston

The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples over a period of 12 months. All 2-dose participants will be offered a 3rd dose after the final blood draw,12 months after their initial vaccination.

Sponsor: The University of Texas Medical Branch, Galveston

Who Can Participate

Inclusion Criteria

Females 27-45 years old.
Ability to give informed consent.
Has not received any prior doses of the HPV vaccine. This will be verified by the person and state registry (Immtrac), as well as the person's electronic medical record.
Reliable telephone access for the duration of the project.
Can read and speak in either English or Spanish.
Identified source of funding for vaccine such as Medicaid, private health insurance, Texas Healthy Women program, etc.
Reports consistent use of reliable birth control and plans to continue its use through study month 13.

Exclusion Criteria

Currently pregnant or plans to become pregnant or donate eggs in the next 13 months. Any subjects with positive pregnancy tests at the initial visit will be disqualified from the study and advised to seek prenatal care.
Has an immunodeficiency or autoimmune disease such as HIV infection, lymphoma, leukemia, lupus, rheumatoid arthritis, inflammatory bowel disease, or other autoimmune condition.
Currently receiving treatment or medication that can suppress immune function including radiation therapy, chemotherapy, cyclosporin, leflunomide (Arava), TNF-α antagonists, monoclonal antibody therapies (including rituximab \[Rituxan\]), intravenous gamma globulin (IVIG), antilymphocyte sera, other therapy known to interfere with the immune response, or systemic corticosteroids (by mouth or intramuscular injection). Those using or have used steroids that are inhaled, placed in the eye, applied on the skin, or injected into the joint/soft tissue will be considered eligible for the study.
History of splenectomy
Known allergies to any vaccine components, including aluminum, yeast or Benzonase.
Febrile at ≥100°F in the 24 hours prior to vaccination. The patients may be rescheduled for a later date.
History of thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injections.
History of \>10 sexual partners in their lifetime at time of enrollment
Plans to move out of the Galveston/Houston area in the 13 months following study entry.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Galveston?

Yes, this clinical trial (NCT05672927) has an active research site in Galveston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Immunization Treatment Options in Galveston, TX

If you're searching for immunization treatment options in Galveston, TX, this clinical trial (NCT05672927) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Galveston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced immunization specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all immunization clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Galveston, TX

See all multiple myeloma clinical trials recruiting in Galveston — not just this study.

Browse Multiple Myeloma Trials in Galveston →

Browse More Trials by Condition

Multiple Myeloma TrialsVaccine TrialsAll Conditions →

Ready to Join in Galveston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Galveston, TX